Literature DB >> 9797763

Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity.

R W Costello1, D B Jacoby, A D Fryer.   

Abstract

In the lungs neuronal M2 muscarinic receptors limit acetylcholine release from postganglionic cholinergic nerves. These inhibitory M2 receptors are dysfunctional in antigen challenged guinea pigs and in humans with asthma which leads to an increase in vagally mediated hyperreactivity. In vitro, eosinophil products act as allosteric antagonists at neuronal M2 muscarinic receptors. In vivo, displacing or neutralising MBP preserves neuronal M2 muscarinic receptor function and prevents hyperreactivity. Thus, there is good evidence from animal studies that after antigen challenge pulmonary M2 muscarinic receptors become dysfunctional because MBP inhibits their function. Loss of function of pulmonary neuronal M2 muscarinic receptors has also been reported in patients with asthma, although the clinical significance of this dysfunction and the mechanisms underlying it are not yet established.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797763      PMCID: PMC1745261          DOI: 10.1136/thx.53.7.613

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  68 in total

1.  A comparison of the protective effect of fenoterol and Sch 1000 on allergen-induced asthma.

Authors:  R E Ruffin; D W Cockcroft; F E Hargreave
Journal:  J Allergy Clin Immunol       Date:  1978-01       Impact factor: 10.793

2.  Autoradiographic visualization of muscarinic receptors in human bronchi.

Authors:  C J van Koppen; W M Blankesteijn; A B Klaassen; J F Rodrigues de Miranda; A J Beld; C A van Ginneken
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

3.  Sympathetic versus parasympathetic nervous regulation of airways in dogs.

Authors:  G A Cabezas; P D Graf; J A Nadel
Journal:  J Appl Physiol       Date:  1971-11       Impact factor: 3.531

4.  In vivo roentgenographic examination of parasympathetic innervation of small airways. Use of powdered tantalum and a fine focal spot x-ray tube.

Authors:  J A Nadel; G A Cabezas; J H Austin
Journal:  Invest Radiol       Date:  1971 Jan-Feb       Impact factor: 6.016

5.  Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs.

Authors:  C L Elbon; D B Jacoby; A D Fryer
Journal:  Am J Respir Cell Mol Biol       Date:  1995-03       Impact factor: 6.914

6.  Ozone-induced loss of neuronal M2 muscarinic receptor function is prevented by cyclophosphamide.

Authors:  L M Gambone; C L Elbon; A D Fryer
Journal:  J Appl Physiol (1985)       Date:  1994-09

7.  Pancuronium and gallamine are antagonists for pre- and post-junctional muscarinic receptors in the guinea-pig lung.

Authors:  A D Fryer; J Maclagan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

8.  Affinities of pirenzepine for muscarinic cholinergic receptors in membranes isolated from bovine tracheal mucosa and smooth muscle.

Authors:  J M Madison; C A Jones; M Tom-Moy; J K Brown
Journal:  Am Rev Respir Dis       Date:  1987-03

9.  Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma.

Authors:  E Frigas; D A Loegering; G O Solley; G M Farrow; G J Gleich
Journal:  Mayo Clin Proc       Date:  1981-06       Impact factor: 7.616

10.  Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function.

Authors:  A H Schultheis; D J Bassett; A D Fryer
Journal:  J Appl Physiol (1985)       Date:  1994-03
View more
  11 in total

1.  Mutation screening of the muscarinic M(2) and M(3) receptor genes in normal and asthmatic subjects.

Authors:  A G Fenech; M J Ebejer; A E Felice; R Ellul-Micallef; I P Hall
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D.

Authors:  G Hansen; S Jin; D T Umetsu; M Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  Management of acute pediatric asthma.

Authors:  John C Carl; Carolyn M Kercsmar
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

4.  Gantacurium and CW002 do not potentiate muscarinic receptor-mediated airway smooth muscle constriction in guinea pigs.

Authors:  Hiroshi Sunaga; Yi Zhang; John J Savarese; Charles W Emala
Journal:  Anesthesiology       Date:  2010-04       Impact factor: 7.892

Review 5.  The role of neuroeffector mechanisms in the pathogenesis of asthma.

Authors:  G F Joos
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

Review 6.  Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway.

Authors:  Tonio Pera; Raymond B Penn
Journal:  Curr Opin Pharmacol       Date:  2014-04-17       Impact factor: 5.547

7.  Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice.

Authors:  Gitte Jositsch; Tamara Papadakis; Rainer V Haberberger; Miriam Wolff; Jürgen Wess; Wolfgang Kummer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-31       Impact factor: 3.000

8.  Cholinergic connectivity: it's implications for psychiatric disorders.

Authors:  Elizabeth Scarr; Andrew S Gibbons; Jaclyn Neo; Madhara Udawela; Brian Dean
Journal:  Front Cell Neurosci       Date:  2013-05-03       Impact factor: 5.505

9.  Pioglitazone prevents obesity-related airway hyperreactivity and neuronal M2 receptor dysfunction.

Authors:  Becky J Proskocil; Allison D Fryer; David B Jacoby; Zhenying Nie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

Review 10.  Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology.

Authors:  Anatoliy Gladkevich; S Adriaan Nelemans; Henk F Kauffman; Jakob Korf
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.